Cargando…

Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM

BACKGROUND: Lipoprotein (a) (LP (a) is an independent cardiovascular risk factor that is not widely studied in people of sub-Saharan African origin. The aim of this report is to determine the frequency of occurrence of elevated Lp (a) and possible relationship with total cholesterol (TCHOL), high de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogbera, Anthonia O, Azenabor, Alfred O
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919447/ https://www.ncbi.nlm.nih.gov/pubmed/20663222 http://dx.doi.org/10.1186/1758-5996-2-51

Ejemplares similares

Hyperuricaemia and the metabolic syndrome in type 2 DM
por: Ogbera, Anthonia O, et al.
Publicado: (2010)

Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus
por: Azenabor, Alfred, et al.
Publicado: (2011)

Screening for peripheral neuropathy and peripheral arterial disease in persons with diabetes mellitus in a Nigerian University Teaching Hospital
por: Ogbera, Anthonia O., et al.
Publicado: (2015)

The efficacy and safety of Simvastatin in the treatment of lipid abnormalities in diabetes mellitus
por: Okeoghene, Ogbera A., et al.
Publicado: (2013)

Prevalence and gender distribution of the metabolic syndrome
por: Ogbera, Anthonia O
Publicado: (2010)

The metabolic syndrome in thyroid disease: A report from Nigeria
por: Ogbera, Anthonia O., et al.
Publicado: (2012)

Insulin use, prescription patterns, regimens and costs.-a narrative from a developing country
por: Ogbera, Anthonia O, et al.
Publicado: (2012)

Clinical features, predictive factors and outcome of hyperglycaemic emergencies in a developing country
por: Ogbera, Anthonia O, et al.
Publicado: (2009)

Understanding asthma and the metabolic syndrome - a Nigerian report
por: Adeyeye, Olufunke O, et al.
Publicado: (2012)

Characterization of lipid parameters in diabetes mellitus – a Nigerian report
por: Ogbera, Anthonia O, et al.
Publicado: (2009)

Epidemiology of thyroid diseases in Africa
por: Ogbera, Anthonia Okeoghene, et al.
Publicado: (2011)

Colorectal Carcinoma Screening in Lagos, Nigeria, Are We Doing it Right?
por: Onyekwere, Charles A, et al.
Publicado: (2009)

Prevalence of diabetes mellitus in persons with tuberculosis in a tertiary health centre in Lagos, Nigeria
por: Olayinka, Adeyeye Olufunke, et al.
Publicado: (2013)

Hepatitis C Virus (HCV) Prevalence in Special Populations and Associated Risk Factors: A Report From a Tertiary Hospital
por: Onyekwere, Charles Asabamaka, et al.
Publicado: (2016)

Latent Autoimmune Diabetes Mellitus in Adults (LADA) and it’s characteristics in a subset of Nigerians initially managed for type 2 diabetes
por: Adeleye, Olufunmilayo O, et al.
Publicado: (2012)

Serum C-peptide assay of patients with hyperglycemic emergencies at the Lagos State University Teaching Hospital (LASUTH), Ikeja
por: Akinlade, Akinyele Taofiq, et al.
Publicado: (2014)

Glucose and lipid assessment in patients with acute stroke
por: Ogbera, Anthonia O, et al.
Publicado: (2014)

Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome
por: Devaraj, Sridevi, et al.
Publicado: (2010)

Prevalence, Predictive Factors, and Characteristics of Osteoporosis in Hyperthyroid Patients
por: Ale, Ayotunde O., et al.
Publicado: (2018)

Advanced age, altered level of consciousness and a new diagnosis of diabetes are independently associated with hypernatreamia in hyperglycaemic crisis
por: Ekpebegh, Chukwuma O, et al.
Publicado: (2011)

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein
Publicado: (1982)

C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese
por: Dongway, Angelo C, et al.
Publicado: (2015)

Lipoprotein Metabolism Indicators Improve Cardiovascular Risk Prediction
por: van Schalkwijk, Daniël B., et al.
Publicado: (2014)

Treatment of diabetes mellitus-associated neuropathy with vitamin E and Eve primrose
por: Ogbera, Anthonia Okeoghene, et al.
Publicado: (2014)

Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns
por: Olamoyegun, Michael Adeyemi, et al.
Publicado: (2016)

Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy
por: Hyun, Myung Han, et al.
Publicado: (2019)

High-sensitivity C-reactive protein and low-density lipoprotein cholesterol association with incident of cardiovascular events: Isfahan cohort study
por: Nafari, Amirhossein, et al.
Publicado: (2022)

Knowledge of diabetes mellitus in tuberculosis amongst healthcare workers in Nigeria
por: Ogbera, Okeoghene Anthonia, et al.
Publicado: (2013)

High-Sensitivity C-Reactive Protein Relationship with Metabolic Disorders and Cardiovascular Diseases Risk Factors
por: Koziarska-Rościszewska, Małgorzata, et al.
Publicado: (2021)

Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins
Publicado: (1984)

Synergistic effect of lipoprotein (a) and C-reactive protein on prognosis of familial hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial
por: Hwang, You‐Cheol, et al.
Publicado: (2017)

Effect of different training mode on Interleukin-6 (IL-6) and C-reactive protein (CRP) in type 2 diabetes mellitus (T2DM) patients
por: Kim, Kwi Baek
Publicado: (2014)

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies
por: Ray, Kausik K., et al.
Publicado: (2019)

The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults
por: Chiu, Feng-Hsiang, et al.
Publicado: (2012)

Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study
por: Paschoal, Renato Soriani, et al.
Publicado: (2018)

Are oxidized low-density lipoprotein and C-reactive protein markers of atherosclerosis in nephrotic children?
por: Rybi-Szumińska, A., et al.
Publicado: (2014)

Conformationally Altered C-Reactive Protein Capable of Binding to Atherogenic Lipoproteins Reduces Atherosclerosis
por: Pathak, Asmita, et al.
Publicado: (2020)

Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT)
por: Appiah, Lambert Tetteh, et al.
Publicado: (2020)

Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?
por: Julius, Ulrich, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_40cop2vbvhpi26d4791gjgju9l